AI Bias Analysis
4 models · Takes ~15 seconds
A change to FDA clinical trial data review, Rocket sells its priority review voucher, and more biotech news from The Readout
Source
Stat News
Opens original article in a new tab
(MedPage Today) -- The expert interviewed for this article is an internationally recognized specialist in the management of solid tumors and served as a paid consultant to Daiichi Sankyo and AstraZeneca on this article's content. Solid tumors...
(MedPage Today) -- Note that some links may require registration or subscription. The FDA warned of three deaths associated with Bolton Medical RelayPro thoracic stent graft systems recalled over an issue where the graft is unable to unclasp from...
The FDA announced efforts to make clinical trials more efficient, starting by reviewing data in real time from trials conducted by AstraZeneca and Amgen
(MedPage Today) -- Even though fewer physicians are being sued for medical malpractice each year, liability premiums have still been rising, according to two reports from the American Medical Association (AMA). The percentage of practicing physicians...
